BMI modifies the association between serum lipids and metabolic dysfunction-associated fatty liver disease: a cross-sectional study in a hospital-based high-risk population
Frontiers in Physiology · 18.11.2026 · 17
DOI: 10.3389/fphys.2026.1923243 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Frontiers in Physiology, online erschienen am 18.11.2026. Verfasst von Ruibing Qi und 6 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
To investigate the associations of low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) with metabolic dysfunction-associated fatty liver disease (MAFLD), with a specific focus on the effect modification by body mass index (BMI) and the unique role of TG.
Methods
This cross-sectional study included 7035 participants who underwent FibroTouch examinations. Multivariable logistic regression, restricted cubic splines, subgroup analyses, additive interaction analyses, and ROC curves were used to assess the associations between lipid parameters and MAFLD.
Results
Elevated LDL-C, non-HDL-C, and TG were positively associated with MAFLD, while HDL-C was negatively associated (all p < 0.001). All lipid-MAFLD associations were significantly modified by BMI (all P for interaction < 0.001), with stronger associations in non-overweight individuals. Only TG showed a significant synergistic effect with high BMI (RERI = 12.99, 95% CI: 7.59–19.84) and had the highest AUC (AUC = 0.759). However, no lipid parameters were independently associated with significant liver fibrosis.
Conclusion
In this hospital-based population undergoing metabolic-liver assessment, the associations between lipid parameters and MAFLD were universally modified by BMI, with stronger associations observed in non-overweight individuals. TG may play a unique dual role: it appeared to be the strongest correlate of MAFLD among lipid parameters in non-overweight individuals, showed a synergistic effect with BMI in overweight/obese individuals, and had the highest AUC among single lipid parameters for MAFLD. In clinical practice, hypertriglyceridemia in non-overweight individuals may warrant attention, and the combined effect of high TG and high BMI in overweight/obese individuals could be recognized.
Zitieren
APA
Qi, R., Jiang, J., Wu, X., Zhang, S., Chen, X., Yu, J., & Li, Z. (2026). BMI modifies the association between serum lipids and metabolic dysfunction-associated fatty liver disease: a cross-sectional study in a hospital-based high-risk population. Frontiers in Physiology, 17. https://doi.org/10.3389/fphys.2026.1923243
Vancouver
Qi R, Jiang J, Wu X, Zhang S, Chen X, Yu J, et al. BMI modifies the association between serum lipids and metabolic dysfunction-associated fatty liver disease: a cross-sectional study in a hospital-based high-risk population. Frontiers in Physiology. 2026;17. doi:10.3389/fphys.2026.1923243
BibTeX
@article{Qi2026,
author = {Qi, Ruibing and Jiang, Jiaqin and Wu, Xingye and Zhang, Shisi and Chen, Xiaoying and Yu, Jinming and Li, Zhengming},
title = {BMI modifies the association between serum lipids and metabolic dysfunction-associated fatty liver disease: a cross-sectional study in a hospital-based high-risk population},
journal = {Frontiers in Physiology},
year = {2026},
volume = {17},
doi = {10.3389/fphys.2026.1923243}
}
EUVIMED